US FDA and EMA accept application for Novartis’ Beovu to treat DME

Beovu application was accepted by the Japanese Pharmaceuticals and Medical Devices Agency for treatment of DME. Credit: National Eye Institute, National Institutes of Health/ Wikipedia.org.